1.北京中医药大学 北京 100029
2.北京中医药大学东方医院
杜若芳,女,在读硕士生
# 曹阳,女,硕士,教授、主任医师,硕士生导师,E-mail:13681050363@163.com
纸质出版日期:2022-07-30,
收稿日期:2021-05-24,
移动端阅览
杜若芳, 梁秋然, 曹阳. 从阴阳虚损理论探讨乳腺癌的中医证治[J]. 现代中医临床, 2022,29(4):65-68.
Ruofang DU, Qiuran LIANG, Yang CAO. Discussion on TCM syndromes and treatment of breast cancer from the theory of Yin-Yang deficiency[J]. Modern Chinese Clinical Medicine, 2022,29(4):65-68.
杜若芳, 梁秋然, 曹阳. 从阴阳虚损理论探讨乳腺癌的中医证治[J]. 现代中医临床, 2022,29(4):65-68. DOI: 10.3969/j.issn.2095-6606.2022.04.013.
Ruofang DU, Qiuran LIANG, Yang CAO. Discussion on TCM syndromes and treatment of breast cancer from the theory of Yin-Yang deficiency[J]. Modern Chinese Clinical Medicine, 2022,29(4):65-68. DOI: 10.3969/j.issn.2095-6606.2022.04.013.
乳腺癌是女性最常见的恶性肿瘤之一,在西医治疗的基础上配合中医治疗能极大改善乳腺癌患者的预后。阴阳虚损是乳腺癌的基本病机,可从阳虚证、阴虚证论治乳腺癌。乳腺癌以阳虚为主者,易感风寒湿等外邪,阳虚失于温煦、推动,日久酿成痰湿血瘀,表现为病变局部早期肿势弥漫、皮色不变、不痛不痒及全身阳虚的证候特点,证似阴疽,治以阳和汤。乳腺癌以阴虚为主者,邪入肝络为病,伏于营血,日久化热,表现为病变局部更易溃烂、转移、向晚期进展及全身阴虚的证候特点,证似邪伏阴分,治以青蒿鳖甲汤。在阴中求阳、阳中求阴的理论指导下,结合整体正虚、局部邪实的疾病特点,可阳和汤和青蒿鳖甲汤联合应用,并配合外治。
Breast cancer is one of the most common malignant tumors in women. Combined treatment of traditional Chinese medicine based on Western medicine can greatly improve its prognosis. Deficiency of Yin and Yang constitutes the primary pathogenesis of breast cancer
and hence its treatment can be performed from the aspects of Yang deficiency syndrome and Yin deficiency syndrome. For patients with the Yang-deficiency breast cancer
there is a high risk of affection by exogenous pathogenic factors of wind
cold and dampness; and patients may lose the abilities of Qi-promotion and Qi-warming
leading to phlegm dampness blood stasis with time eventually. These patients may manifest the syndrome characteristics of scattered swelling
unchanged skin color
no pain or itching and systemic Yang deficiency in the early stage of the lesion. Its syndrome shares similarities with "carbuncles of Yin nature"
and it can be treated with
Yanghe
Decoction. Meanwhile
for patients with Yin-deficiency breast cancer
there is a risk of pathogenic factors invading the hepatic collaterals
which may remain in the Ying-blood and cause heat transmission over time. These patients may manifest the syndrome characteristics of high risk of local ulceration
metastasis
progression to late stage and systemic Yin deficiency. Its syndrome is similar to a "pathogen lurking in the Yin phase"
and it can be treated with
Qinghao Biejia
Decoction. Significantly
under the guidance of the theory of reinforcing Yang from Yin and reinforcing Yin from Yang and considering the disease characteristics of systemic deficiency of healthy Qi and local excess of pathogenic factors
Yanghe
Decoction and
Qinghao Biejia
Decoction can also be applied jointly
associated with external treatment.
乳腺肿瘤阳虚阴虚阳和汤青蒿鳖甲汤
breast neoplasmsYang deficiencyYin deficiencyYanghe DecoctionQinghao Biejia Decoction
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021,71(3):209-249.
张介宾.类经[M].郭洪耀,吴少祯,校注.北京:中国中医药出版社,1997:7.
张介宾.景岳全书[M].夏之秋,校注.北京:中国中医药出版社,1994.
王丽,李平.论因机诊治及在恶性肿瘤防治中的应用[J].北京中医药大学学报,2021,44(4):374-379.
陈自明.校注妇人良方[M].薛己,校注.上海:科技卫生出版社,1958:552.
余景和.外证医案汇编[M].尚冰,校注.北京:中国中医药出版社,2015.
李中梓.医宗必读[M].王卫,张艳军,徐立,等,点校.天津:天津科学技术出版社,1999:256.
董青,董雪燕,李忠,等.基于中医古籍探索乳腺癌认知源流 [J].北京中医药,2019,38(4):355-359.
巢元方.诸病源候论[M].鲁兆麟,主校.沈阳:辽宁科学技术出版社,1997.
窦汉卿.疮疡经验全书[M].任玉兰,王一童,孙天晓,等,校注.北京:中国中医药出版社,2021:105.
陈荡,曾柏荣,段航,等.基于太少两感探讨阳和汤治疗乳腺癌机制[J].中医药临床杂志,2020,32(1):51-54.
王维德.外科证治全生集[M].胡晓峰,整理.北京:人民卫生出版社,2006.
陈实功.外科正宗[M].裘钦豪,高葆良,杜江南,点校.上海:上海科学技术出版社,1989:173.
李冀.方剂学[M].北京:中国中医药出版社,2012:112.
王清任.医林改错[M].鲁兆麟,主校.沈阳:辽宁科学技术出版社,1997:9.
白东媛.中药治疗HR阴性乳腺癌生存情况观察及影响因素分析[D].北京:北京中医药大学,2019.
吴谦.医宗金鉴[M].刘国正,刘振远,王树芬,等,校注.北京:中医古籍出版社,1995:801.
范顺,石冲,尚懿纯.初探温病中“先入后出”之法[J].中医学报,2020,35(9):1846-1848.
俞根初.重订通俗伤寒论[M].徐荣斋,重订.上海:上海卫生出版社,1956:14.
林培政,谷晓红.温病学[M].北京:中国中医药出版社,2012:229.
朱震亨.格致余论[M].鲁兆麟,主校.沈阳:辽宁科学技术出版社,1997:9.
吴瑭.温病条辨[M].文棣,校注.北京:中国书店,1994.
张天星.《黄帝内经》“重阴必阳,重阳必阴”新解[J].北京中医药大学学报,2020,43(1):17-20.
0
浏览量
24
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构